Xiaohang Qiao
Papers
1
Total Citations
32
H-Index
1
About
Xiaohang Qiao is a cancer researcher whose work focuses on identifying novel therapeutic strategies to enhance the efficacy of radiotherapy. Her most cited paper, published in 2017, reports the discovery of a new ATM inhibitor that selectively radiosensitizes cancer cells, a breakthrough with significant implications for improving treatment outcomes in head and neck oncology. This study, which has garnered 32 citations, highlights Qiao's expertise in molecular oncology and drug development, particularly in targeting DNA damage repair pathways to overcome radioresistance. Collaborating with leading scientists at institutions such as the Netherlands Cancer Institute and the University of Amsterdam, Qiao's contributions bridge preclinical discovery and translational potential. Her work not only advances understanding of ATM kinase inhibition but also offers a promising avenue for reducing normal tissue toxicity while enhancing tumor cell death. For students and researchers in cancer biology, Qiao's research exemplifies how mechanistic insights into cellular stress responses can lead to tangible clinical applications, making her a notable figure in the field of radiation oncology and targeted cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1